Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
SC 13G
NextCure, Inc.
1 Apr 24
SC 13G
Adverum Biotechnologies, Inc.
22 Feb 24
SC 13G/A
Allakos Inc.
14 Feb 24
SC 13G/A
Spyre Therapeutics, Inc.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G/A
IDEAYA Biosciences, Inc.
13 Feb 24
SC 13G/A
Annexon, Inc.
13 Feb 24
SC 13G
Elevation Oncology, Inc.
22 Jan 24
SC 13G
Unicycive Therapeutics, Inc.
22 Jan 24
SC 13G
aTYR PHARMA INC
2 Jan 24
SC 13D/A
Olema Pharmaceuticals, Inc.
28 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13G
Aeglea BioTherapeutics, Inc.
18 Jul 23
SC 13G
Annexon, Inc.
22 Jun 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
SC 13G/A
Allakos Inc.
14 Feb 23
SC 13G/A
IDEAYA Biosciences, Inc.
14 Feb 23
SC 13G/A
Dyne Therapeutics, Inc.
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
SC 13G/A
BICYCLE THERAPEUTICS plc
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
SC 13G
Allakos Inc.
28 Sep 22
13F-HR
Quarterly holdings report by institutional manager
15 Aug 22
13F-HR
Quarterly holdings report by institutional manager
16 May 22
SC 13G
BICYCLE THERAPEUTICS plc
2 May 22
SC 13D
Design Therapeutics, Inc.
31 Mar 22
SC 13G
IDEAYA Biosciences, Inc.
18 Mar 22
SC 13G/A
Harpoon Therapeutics, Inc.
15 Feb 22
SC 13G/A
Dyne Therapeutics, Inc.
14 Feb 22
SC 13G/A
BICYCLE THERAPEUTICS plc
14 Feb 22
SC 13G/A
Kezar Life Sciences, Inc.
14 Feb 22
SC 13G/A
Viridian Therapeutics, Inc.\DE
14 Feb 22
SC 13G/A
Cogent Biosciences, Inc.
14 Feb 22
SC 13G/A
Nkarta, Inc.
14 Feb 22
13F-HR
Quarterly holdings report by institutional manager
14 Feb 22
SC 13G/A
Aligos Therapeutics, Inc.
14 Feb 22
SC 13G/A
Eledon Pharmaceuticals, Inc.
26 Jan 22
SC 13G
Harpoon Therapeutics, Inc.
27 Dec 21